- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 217/12 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
Patent holdings for IPC class C07D 217/12
Total number of patents in this class: 93
10-year publication summary
|
6
|
9
|
4
|
6
|
7
|
3
|
4
|
1
|
5
|
2
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Epizyme, Inc. | 366 |
9 |
| Bristol-myers Squibb Company | 4795 |
4 |
| Celgene Quanticel Research, Inc. | 158 |
3 |
| Taisho Pharmaceutical Co., Ltd. | 863 |
3 |
| Toyama Chemical Co., Ltd. | 96 |
3 |
| Antabio SAS | 23 |
2 |
| ConSynance Therapeutics, Inc. | 8 |
2 |
| Enanta Pharmaceuticals, Inc. | 433 |
2 |
| Flexus Biosciences, Inc. | 13 |
2 |
| Georgia State University Research Foundation, Inc. | 352 |
2 |
| Olema Pharmaceuticals, Inc. | 60 |
2 |
| Samumed, LLC | 66 |
2 |
| Wuhan LL Science and Technology Development Co., Ltd | 73 |
2 |
| Lapix Therapeutics, Inc. | 18 |
2 |
| The Regents of the University of California | 20410 |
1 |
| Merck Sharp & Dohme Corp. | 2186 |
1 |
| Janssen Pharmaceutica N.V. | 3304 |
1 |
| Pfizer Inc. | 3373 |
1 |
| Wyeth LLC | 636 |
1 |
| The Trustees of Columbia University in the City of New York | 3615 |
1 |
| Other owners | 47 |